Zobrazeno 1 - 10
of 11
pro vyhledávání: '"James H. Sampson"'
Autor:
Lawrence Fox, Eileen T. Denning, H. Clifford Lane, Donald I. Abrams, Norman P. Markowitz, Rita Verheggen, Douglas Zeh, Richard T. Davey, Judith D. Bebchuk, James H. Sampson
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 29:221-231
The effect of intermittent courses of recombinant interleukin-2 (rIL-2) on HIV-1 load in patients receiving combination antiretroviral therapy remains uncertain. CPCRA 059 was an open-label, randomized, multicenter trial in which 511 patients with HI
Autor:
David C. Perlman, Glenn E. Bartsch, Linnea Capps, Steven Schnittman, Richard W. Price, James H. Sampson, James D. Neaton, E. J. Fisher, Eric A. Krum, Lisa A. Green, Lawrence Deyton, Frank S. Rhame
Publikováno v:
AIDS. 12:1983-1990
Objectives To describe the methods and results of a standardized system for clinical endpoint determination for defining and reviewing endpoints in clinical trials for HIV-infected individuals. Design A system was developed utilizing standard definit
Autor:
Ramon A. Torres, Renslow Sherer, Michael R. Barr, Donald I. Abrams, James H. Sampson, James D. Neaton, Thomas T. Ward, Deborah Wentworth
Publikováno v:
Clinical Infectious Diseases. 26:85-90
To examine the relationship between acyclovir use and survival in AIDS, we performed a retrospective analysis of data collected through an observational cohort of the 17-site Community Program for Clinical Research on AIDS (CPCRA), under the sponsors
Autor:
David L. Cohn, Sandra Kornegay, Katherine Muth, Allen Harris, James H. Sampson, Anne I. Goldman, Lawrence Deyton, Michael Grodesky, Steven Wakefield, Joyce A. Korvick, Donald I. Abrams, Melanie A. Thompson, Lawrence R. Crane, Norman Markowitz, James D. Neaton, Cynthia A. Launer, Roberta Luskin-Hawk
Publikováno v:
New England Journal of Medicine. 330:657-662
Background Both didanosine and zalcitabine are commonly used to treat patients with human immunodeficiency virus (HIV) infection who cannot tolerate zidovudine treatment or who have had disease progression despite it. The relative efficacy and safety
Autor:
Wafaa El-Sadr, David A. Cooper, Nicki Smith, Gregg Larson, Patty Bollenbeck, John Worley, Chloe Orkin, Daniela Gey, Andrzej Horban, Maxime Seligmann, Greg Thompson, Ray Nelson, David Courtney-Rodgers, Valerie Beral, Adriana Sanchez, John Chuah, Karoline Jensen, Ann M. Labriola, Jens D Lundgren, Ronald J. Prineas, Marcelo H. Losso, Richard J. Price, Billy Pick, Maria C. Rodriguez-Barradas, Norman Markowitz, J Vera, Bitten Aagaard, Karen Hennessey, Gustavo Lopardo, Cate Carey, Daniel E. Nixon, Eileen Denning, Liselotte Borup, Barbara E. Murray, Richard E. Chaisson, Christopher Hill, Kamal Mansinho, Martin J. Wiselka, Shawn K. Brown, Hakima Himmich, Jo Watson, Fionna Van Hooff, Janet Darbyshire, Frank S. Rhame, Jessica Horton, Court Pederson, Jesper Grarup, John F. Modlin, Jonathan P. Anderson, Dwight E. Peavy, Claire Rappoport, Merrie Harrison, Siu Fun L. Quan, Barbara Standridge, Julie Eckstrand, Pacharee Kantipong, Fred M. Gordin, Jorge A. Tavel, Ana Martinez, Juan Carlos López, Lisa Fosdick, Ploenchan Chetchotisakd, Ian Weller, James D. Neaton, Doug Thomas, Elizabeth Finley, Simon Portsmouth, Mirta Valdez, Waldo H. Belloso, Giuseppe Tambussi, Nicholas I. Paton, Vanita Costas, Nafisah Braimah, Sergio H. Lupo, Simon Collins, Terri Schultz, Siegfried Schwarze, David Haerry, Kien Quan, Daniel Duprez, James H. Sampson, Thomas R. Fleming, Kyung Mann Kim, Eric A. Krum, Gregory M. Anstead, Matthew Bidwell Goetz, Marcelo Wolff, Deborah Wentworth, Stefano Rusconi, Søren Reilev, Abdel Babiker, Eleanor King, Francisco Antunes, Sean Emery, David Orth, Per O. Jansson, Lawrence Fox, Martin Fisher, Mary Anne Luzar, Alan R. Lifson, David Mollerup, Rick Davey, Alan Winston, Jenny Hoy, Kiat Ruxrungtham, Michael Meulbroek, Nicole Wyman, Judith Bebchuk, José M. Gatell, Alain G. DuChene, David Munroe, Roberto C. Arduino, George Perez, Mark James Kelly
Publikováno v:
PLoS ONE
PLoS ONE, Vol 5, Iss 2, p e9334 (2010)
PloS one, vol 5, iss 2
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
PLoS ONE, Vol 5, Iss 2, p e9334 (2010)
PloS one, vol 5, iss 2
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
BACKGROUND: The Study of Aldesleukin with and without antiretroviral therapy (STALWART) evaluated whether intermittent interleukin-2 (IL-2) alone or with antiretroviral therapy (ART) around IL-2 cycles increased CD4(+) counts compared to no therapy.
Autor:
Carol L. Brosgart, E. J. Fisher, James H. Sampson, David L. Cohn, Barry Schmetter, Wafaa El-Sadr, Kathryn Chaloner, Lisa Bjorling Grant, Beverly Alston
Publikováno v:
AIDS (London, England). 15(13)
OBJECTIVE Efficacy and safety of adefovir dipivoxil (adefovir) added to background antiretroviral therapy in advanced HIV disease. DESIGN Randomized, double-blind, placebo-controlled multicenter trial. SETTING Fifteen clinical trial units providing H
Autor:
Joseph G. Timpone, David J. Wright, Ning Li, Merrill J. Egorin, Mary E. Enama, Jacqueline Mayers, Giorgio Galetto, Suzanne Gagnon, Jeri Vargo, Keith Chirgwin, Adrien Marcel, David Cohn, Beverly Hopkins, Michael Dudley, Sandra Geletko, Harold Standiford, Karen Cervino, Debra Greenspan, David M. Mushatt, William Powderly, Mark Meyers, James H. Sampson, Gregory McMillan, Richard Novak, Luiz Moreira
Publikováno v:
Marihuana and Medicine ISBN: 9781475757170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd7f7c372d2bbfa9b79d968214a726f9
https://doi.org/10.1007/978-1-59259-710-9_69
https://doi.org/10.1007/978-1-59259-710-9_69
Autor:
David C. Perlman, Glenn E. Bartsch, Frank S. Rhame, James D. Neaton, James H. Sampson, Lisa A. Green, Linnea Capps, Lawrence Deyton, Steven M. Schnittman, Richard W. Price, Marcella Myers, Gerald Friedland, Eric A. Krum
Publikováno v:
Controlled Clinical Trials. 16:58S-59S
Autor:
Sandra Melnick, Jane Sanvffle, Michelle Hardy, David Townley, William Valuer, Karen Irvin, Melanie A. Thompson, James D. Neaton, Amy Morris, Joyce A. Korvick, James H. Sampson, Thomas A. Louis, Nancy Kimmel, Kathryn Anastos, Diane Mastro-Polak, Linnea Capps, Renee Renzetti, Dean L. Winslow, Jeffrey Kocher, Norman Markowitz, Jones Kumi, Carol A. Mesard, Renslow Sherer, Arlene Bincsik, Mordechai Bar, Phyllis Simmons, Annemarie Sheridan, Rita Verheggen, Jerome Ernst, Janet Y. Lee, Tim Brelje, Jack Ebright, Kathleen Clanon, Jill Hutchinson, Evelyn Fisher, Joel Godbey, Evelyn M. Rodriguez, Bea Morris, William Owen, Lawrence Gernon, Lawrence S. Brown, Norma Martinez, Marcia Carlyn, Mark Loveless, Jan Walker, Luis Fuentes, Alain DuChene, Lawrence R. Deyton, William J. Holloway, Susan Szabo, Karen Swanson, Michael J. Grodesky, Ami Labriola, Kurt Link, Roberta Luskin-Hawk, Thomas M. Kerkering, Cathy Pollard, Ramon A. Torres, Cheryl Lackman, Mary Foulkes, Victoria M. Taylor, Louis Saravolatz, Elizabeth Doramajian, Paula Schuman, Carol Brosgart, Stanley Johns, Steven Weisholtz, Micheal J. Hickson, Greg Thompson, Scott Jp, Sue Pablovich, Joan E. Gans, David Hillman, Elizabeth Finley, Catherine Salveson, Randall Reves, Jilleen Braithwaite, David Moore, David L. Cohn, Carol Webster, Cheryl Guity, Colleen Fairclough, Cynthia L. Gibert, Lawrence R. Crane, Terri Creagh, Deborah Wentworth, Wafaa El-Sadr, Lawrence Deyton, David Blatt, Jacquelyn Ellison
Publikováno v:
JAMA. 272:1915
Objective. —To compare disease progression and mortality between women and men infected with human immunodeficiency virus (HIV). Design. —Multicenter cohort. Setting. —Seventeen community-based centers participating in the Terry Beirn Community
Autor:
Joseph C. Gathe, Stephen E. Follansbee, Stanley C. Deresinski, Daniel J. Lancaster, Paul T. Caldwell, Richard D. Meyer, Ramon A. Torres, Jared Spotkov, Michael N. Dohn, Janna D. Scott, Winkler G. Weinberg, James H. Sampson, Dennis P. Haghighat
Publikováno v:
Annals of Internal Medicine. 121:174
Objective: To test the hypothesis that the therapeutic success rate of oral atovaquone is not worse than that of intravenous pentamidine in the primary treatment of mild and moderate Pneumocystis c...